OTC Inactive Ingredient Labeling Exemption Requested - Citizen Petition
This article was originally published in The Rose Sheet
Executive Summary
An across-the-board inactive ingredient variance on labeling for OTC drug products with differing ingredients from multiple suppliers is requested in a citizen petition filed with FDA May 16. A slightly revised petition followed on May 23.
You may also be interested in...
OTC Label Exemption Procedure Clarification Urged By CTFA
FDA should establish a well-defined process for manufacturers filing for exemptions under the OTC labeling final rule, the Cosmetic, Toiletry and Fragrance Association maintains in comments filed with FDA's Division of OTC Drugs Dec. 13.
OTC Labeling Exemption Requests For Ophthalmics Denied By FDA
Two requests for exemptions from certain provisions of the OTC labeling final rule are denied by FDA in Aug. 23 letters. Zee Medical and Automatic Liquid Packaging sought relief from the reg's 6-point type size requirement for their respective OTC ophthalmic products.
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program